Cardiovascular modulation during vagus nerve stimulation therapy in patients with refractory epilepsy
Summary To evaluate the effects of permanent vagal stimulation on cardiovascular system, 10 patients, affected by drug-resistant epilepsy with no primitive cardiovascular pathologies, were assessed prior to VNS surgery. A complete echocardiographic study [conventional and tissue Doppler imaging (TDI...
Gespeichert in:
Veröffentlicht in: | Epilepsy research 2010-12, Vol.92 (2), p.145-152 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 152 |
---|---|
container_issue | 2 |
container_start_page | 145 |
container_title | Epilepsy research |
container_volume | 92 |
creator | Cadeddu, Christian Deidda, Martino Mercuro, Giuseppe Tuveri, Antonella Muroni, Antonella Nocco, Silvio Puligheddu, Monica Maleci, Alberto Marrosu, Francesco |
description | Summary To evaluate the effects of permanent vagal stimulation on cardiovascular system, 10 patients, affected by drug-resistant epilepsy with no primitive cardiovascular pathologies, were assessed prior to VNS surgery. A complete echocardiographic study [conventional and tissue Doppler imaging (TDI)], 24-h blood pressure (BP) monitoring and HRV evaluation were performed. The above mentioned parameters were investigated without any substantial changes to drug treatment during a check-up subsequent to VNS activation [mean: 7.7 months]. The results obtained show that while the anthropometrical data and both conventional and TDI echocardiography were unvaried compared to baseline, BP showed a significant increase of both systodiastolic values. Moreover, a close scrutiny of the most affected period of the BP increase (zenith between 16:31 and 17:30 pm) (systolic BP 114.7 mmHg vs 95.3 mmHg, P < 0.0001; diastolic BP 70.9 mmHg vs 56.9 mmHg, P < 0.001) showed a significant increase of the high frequencies components (HF) (28.4 ± 2.7 vs 36 ± 5.3, P < 0.05) and a significant reduction in low frequency/HF ratio (2.3 ± 0.3 vs 1.7 ± 0.3, P < 0.0001). The present study confirms the intrinsic cardiovascular safety and reliability of VNS procedures on both BP and HF and LF profiles and suggests that a primitive VNS-mediated central impingement on vagal efferents, independently by the antiepileptic mechanism, correlated to an moderate increase of parasympathetic activity, which in turn might play a protective role in seizure-triggered alterations of cardiovascular dynamic. |
doi_str_mv | 10.1016/j.eplepsyres.2010.08.012 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_954593101</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S092012111000238X</els_id><sourcerecordid>954593101</sourcerecordid><originalsourceid>FETCH-LOGICAL-c490t-fd181d172393da63d5d332ba478934bd3a86a6946c5b98a8b337eca3377281073</originalsourceid><addsrcrecordid>eNqNUsuKFDEUDaI47egvSDbiqtqbR6VSG0EbXzDgQgV3IZXcnklbL5OqHurvTdk9DrjRTS7cnPs65xBCGWwZMPXqsMWxxTEtEdOWQ06D3gLjD8iG6YoXSkv5kGyg5lAwztgFeZLSAQAqkPIxueCglVCq3BDc2ejDcLTJza2NtBt8jlMYeurnGPprerTXc6I9xiPSNIXu7nu6wWjHhYaejjmD_ZTobZhuaMR9tG4a4kJxDL_XfEoe7W2b8Nk5XpJv79993X0srj5_-LR7c1U4WcNU7D3TzLOKi1p4q4QvvRC8sbLStZCNF1Yrq2qpXNnU2upGiAqdzW_FNYNKXJKXp75jHH7OmCbTheSwbW2Pw5xMXcqyFpnCfyJ1pk1IriEj9Qnp4pBSPs6MMXQ2LoaBWdUwB3OvhlnVMKBNViOXPj8PmZsO_Z_CO_oz4MUZkPm3beatdyHd44QSwMV619sTDjN5x4DRJJcZd-hDRDcZP4T_2eb1X01cG_qQ5_7ABdNhmGOfxTHMJG7AfFnds5qHZd9wob-LXzk_xCA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>812134280</pqid></control><display><type>article</type><title>Cardiovascular modulation during vagus nerve stimulation therapy in patients with refractory epilepsy</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Cadeddu, Christian ; Deidda, Martino ; Mercuro, Giuseppe ; Tuveri, Antonella ; Muroni, Antonella ; Nocco, Silvio ; Puligheddu, Monica ; Maleci, Alberto ; Marrosu, Francesco</creator><creatorcontrib>Cadeddu, Christian ; Deidda, Martino ; Mercuro, Giuseppe ; Tuveri, Antonella ; Muroni, Antonella ; Nocco, Silvio ; Puligheddu, Monica ; Maleci, Alberto ; Marrosu, Francesco</creatorcontrib><description>Summary To evaluate the effects of permanent vagal stimulation on cardiovascular system, 10 patients, affected by drug-resistant epilepsy with no primitive cardiovascular pathologies, were assessed prior to VNS surgery. A complete echocardiographic study [conventional and tissue Doppler imaging (TDI)], 24-h blood pressure (BP) monitoring and HRV evaluation were performed. The above mentioned parameters were investigated without any substantial changes to drug treatment during a check-up subsequent to VNS activation [mean: 7.7 months]. The results obtained show that while the anthropometrical data and both conventional and TDI echocardiography were unvaried compared to baseline, BP showed a significant increase of both systodiastolic values. Moreover, a close scrutiny of the most affected period of the BP increase (zenith between 16:31 and 17:30 pm) (systolic BP 114.7 mmHg vs 95.3 mmHg, P < 0.0001; diastolic BP 70.9 mmHg vs 56.9 mmHg, P < 0.001) showed a significant increase of the high frequencies components (HF) (28.4 ± 2.7 vs 36 ± 5.3, P < 0.05) and a significant reduction in low frequency/HF ratio (2.3 ± 0.3 vs 1.7 ± 0.3, P < 0.0001). The present study confirms the intrinsic cardiovascular safety and reliability of VNS procedures on both BP and HF and LF profiles and suggests that a primitive VNS-mediated central impingement on vagal efferents, independently by the antiepileptic mechanism, correlated to an moderate increase of parasympathetic activity, which in turn might play a protective role in seizure-triggered alterations of cardiovascular dynamic.</description><identifier>ISSN: 0920-1211</identifier><identifier>EISSN: 1872-6844</identifier><identifier>DOI: 10.1016/j.eplepsyres.2010.08.012</identifier><identifier>PMID: 20863665</identifier><identifier>CODEN: EPIRE8</identifier><language>eng</language><publisher>Kidlington: Elsevier B.V</publisher><subject>Adolescent ; Adult ; Anticonvulsants. Antiepileptics. Antiparkinson agents ; Biological and medical sciences ; Blood pressure ; Blood Pressure - physiology ; Electrocardiography - methods ; Epilepsy - physiopathology ; Epilepsy - therapy ; Female ; Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy ; Heart Rate - physiology ; Heart rate variability ; Humans ; Male ; Medical sciences ; Middle Aged ; Nervous system (semeiology, syndromes) ; Neurology ; Neuropharmacology ; Outcome Assessment (Health Care) - methods ; Pharmacology. Drug treatments ; Refractory epilepsy ; Statistics, Nonparametric ; Tissue Doppler imaging ; Vagus nerve stimulation ; Vagus Nerve Stimulation - methods ; Young Adult</subject><ispartof>Epilepsy research, 2010-12, Vol.92 (2), p.145-152</ispartof><rights>Elsevier B.V.</rights><rights>2010 Elsevier B.V.</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2010 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c490t-fd181d172393da63d5d332ba478934bd3a86a6946c5b98a8b337eca3377281073</citedby><cites>FETCH-LOGICAL-c490t-fd181d172393da63d5d332ba478934bd3a86a6946c5b98a8b337eca3377281073</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.eplepsyres.2010.08.012$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23630237$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20863665$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cadeddu, Christian</creatorcontrib><creatorcontrib>Deidda, Martino</creatorcontrib><creatorcontrib>Mercuro, Giuseppe</creatorcontrib><creatorcontrib>Tuveri, Antonella</creatorcontrib><creatorcontrib>Muroni, Antonella</creatorcontrib><creatorcontrib>Nocco, Silvio</creatorcontrib><creatorcontrib>Puligheddu, Monica</creatorcontrib><creatorcontrib>Maleci, Alberto</creatorcontrib><creatorcontrib>Marrosu, Francesco</creatorcontrib><title>Cardiovascular modulation during vagus nerve stimulation therapy in patients with refractory epilepsy</title><title>Epilepsy research</title><addtitle>Epilepsy Res</addtitle><description>Summary To evaluate the effects of permanent vagal stimulation on cardiovascular system, 10 patients, affected by drug-resistant epilepsy with no primitive cardiovascular pathologies, were assessed prior to VNS surgery. A complete echocardiographic study [conventional and tissue Doppler imaging (TDI)], 24-h blood pressure (BP) monitoring and HRV evaluation were performed. The above mentioned parameters were investigated without any substantial changes to drug treatment during a check-up subsequent to VNS activation [mean: 7.7 months]. The results obtained show that while the anthropometrical data and both conventional and TDI echocardiography were unvaried compared to baseline, BP showed a significant increase of both systodiastolic values. Moreover, a close scrutiny of the most affected period of the BP increase (zenith between 16:31 and 17:30 pm) (systolic BP 114.7 mmHg vs 95.3 mmHg, P < 0.0001; diastolic BP 70.9 mmHg vs 56.9 mmHg, P < 0.001) showed a significant increase of the high frequencies components (HF) (28.4 ± 2.7 vs 36 ± 5.3, P < 0.05) and a significant reduction in low frequency/HF ratio (2.3 ± 0.3 vs 1.7 ± 0.3, P < 0.0001). The present study confirms the intrinsic cardiovascular safety and reliability of VNS procedures on both BP and HF and LF profiles and suggests that a primitive VNS-mediated central impingement on vagal efferents, independently by the antiepileptic mechanism, correlated to an moderate increase of parasympathetic activity, which in turn might play a protective role in seizure-triggered alterations of cardiovascular dynamic.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Anticonvulsants. Antiepileptics. Antiparkinson agents</subject><subject>Biological and medical sciences</subject><subject>Blood pressure</subject><subject>Blood Pressure - physiology</subject><subject>Electrocardiography - methods</subject><subject>Epilepsy - physiopathology</subject><subject>Epilepsy - therapy</subject><subject>Female</subject><subject>Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy</subject><subject>Heart Rate - physiology</subject><subject>Heart rate variability</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Nervous system (semeiology, syndromes)</subject><subject>Neurology</subject><subject>Neuropharmacology</subject><subject>Outcome Assessment (Health Care) - methods</subject><subject>Pharmacology. Drug treatments</subject><subject>Refractory epilepsy</subject><subject>Statistics, Nonparametric</subject><subject>Tissue Doppler imaging</subject><subject>Vagus nerve stimulation</subject><subject>Vagus Nerve Stimulation - methods</subject><subject>Young Adult</subject><issn>0920-1211</issn><issn>1872-6844</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNUsuKFDEUDaI47egvSDbiqtqbR6VSG0EbXzDgQgV3IZXcnklbL5OqHurvTdk9DrjRTS7cnPs65xBCGWwZMPXqsMWxxTEtEdOWQ06D3gLjD8iG6YoXSkv5kGyg5lAwztgFeZLSAQAqkPIxueCglVCq3BDc2ejDcLTJza2NtBt8jlMYeurnGPprerTXc6I9xiPSNIXu7nu6wWjHhYaejjmD_ZTobZhuaMR9tG4a4kJxDL_XfEoe7W2b8Nk5XpJv79993X0srj5_-LR7c1U4WcNU7D3TzLOKi1p4q4QvvRC8sbLStZCNF1Yrq2qpXNnU2upGiAqdzW_FNYNKXJKXp75jHH7OmCbTheSwbW2Pw5xMXcqyFpnCfyJ1pk1IriEj9Qnp4pBSPs6MMXQ2LoaBWdUwB3OvhlnVMKBNViOXPj8PmZsO_Z_CO_oz4MUZkPm3beatdyHd44QSwMV619sTDjN5x4DRJJcZd-hDRDcZP4T_2eb1X01cG_qQ5_7ABdNhmGOfxTHMJG7AfFnds5qHZd9wob-LXzk_xCA</recordid><startdate>20101201</startdate><enddate>20101201</enddate><creator>Cadeddu, Christian</creator><creator>Deidda, Martino</creator><creator>Mercuro, Giuseppe</creator><creator>Tuveri, Antonella</creator><creator>Muroni, Antonella</creator><creator>Nocco, Silvio</creator><creator>Puligheddu, Monica</creator><creator>Maleci, Alberto</creator><creator>Marrosu, Francesco</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7TK</scope></search><sort><creationdate>20101201</creationdate><title>Cardiovascular modulation during vagus nerve stimulation therapy in patients with refractory epilepsy</title><author>Cadeddu, Christian ; Deidda, Martino ; Mercuro, Giuseppe ; Tuveri, Antonella ; Muroni, Antonella ; Nocco, Silvio ; Puligheddu, Monica ; Maleci, Alberto ; Marrosu, Francesco</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c490t-fd181d172393da63d5d332ba478934bd3a86a6946c5b98a8b337eca3377281073</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Anticonvulsants. Antiepileptics. Antiparkinson agents</topic><topic>Biological and medical sciences</topic><topic>Blood pressure</topic><topic>Blood Pressure - physiology</topic><topic>Electrocardiography - methods</topic><topic>Epilepsy - physiopathology</topic><topic>Epilepsy - therapy</topic><topic>Female</topic><topic>Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy</topic><topic>Heart Rate - physiology</topic><topic>Heart rate variability</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Nervous system (semeiology, syndromes)</topic><topic>Neurology</topic><topic>Neuropharmacology</topic><topic>Outcome Assessment (Health Care) - methods</topic><topic>Pharmacology. Drug treatments</topic><topic>Refractory epilepsy</topic><topic>Statistics, Nonparametric</topic><topic>Tissue Doppler imaging</topic><topic>Vagus nerve stimulation</topic><topic>Vagus Nerve Stimulation - methods</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cadeddu, Christian</creatorcontrib><creatorcontrib>Deidda, Martino</creatorcontrib><creatorcontrib>Mercuro, Giuseppe</creatorcontrib><creatorcontrib>Tuveri, Antonella</creatorcontrib><creatorcontrib>Muroni, Antonella</creatorcontrib><creatorcontrib>Nocco, Silvio</creatorcontrib><creatorcontrib>Puligheddu, Monica</creatorcontrib><creatorcontrib>Maleci, Alberto</creatorcontrib><creatorcontrib>Marrosu, Francesco</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Neurosciences Abstracts</collection><jtitle>Epilepsy research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cadeddu, Christian</au><au>Deidda, Martino</au><au>Mercuro, Giuseppe</au><au>Tuveri, Antonella</au><au>Muroni, Antonella</au><au>Nocco, Silvio</au><au>Puligheddu, Monica</au><au>Maleci, Alberto</au><au>Marrosu, Francesco</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cardiovascular modulation during vagus nerve stimulation therapy in patients with refractory epilepsy</atitle><jtitle>Epilepsy research</jtitle><addtitle>Epilepsy Res</addtitle><date>2010-12-01</date><risdate>2010</risdate><volume>92</volume><issue>2</issue><spage>145</spage><epage>152</epage><pages>145-152</pages><issn>0920-1211</issn><eissn>1872-6844</eissn><coden>EPIRE8</coden><abstract>Summary To evaluate the effects of permanent vagal stimulation on cardiovascular system, 10 patients, affected by drug-resistant epilepsy with no primitive cardiovascular pathologies, were assessed prior to VNS surgery. A complete echocardiographic study [conventional and tissue Doppler imaging (TDI)], 24-h blood pressure (BP) monitoring and HRV evaluation were performed. The above mentioned parameters were investigated without any substantial changes to drug treatment during a check-up subsequent to VNS activation [mean: 7.7 months]. The results obtained show that while the anthropometrical data and both conventional and TDI echocardiography were unvaried compared to baseline, BP showed a significant increase of both systodiastolic values. Moreover, a close scrutiny of the most affected period of the BP increase (zenith between 16:31 and 17:30 pm) (systolic BP 114.7 mmHg vs 95.3 mmHg, P < 0.0001; diastolic BP 70.9 mmHg vs 56.9 mmHg, P < 0.001) showed a significant increase of the high frequencies components (HF) (28.4 ± 2.7 vs 36 ± 5.3, P < 0.05) and a significant reduction in low frequency/HF ratio (2.3 ± 0.3 vs 1.7 ± 0.3, P < 0.0001). The present study confirms the intrinsic cardiovascular safety and reliability of VNS procedures on both BP and HF and LF profiles and suggests that a primitive VNS-mediated central impingement on vagal efferents, independently by the antiepileptic mechanism, correlated to an moderate increase of parasympathetic activity, which in turn might play a protective role in seizure-triggered alterations of cardiovascular dynamic.</abstract><cop>Kidlington</cop><pub>Elsevier B.V</pub><pmid>20863665</pmid><doi>10.1016/j.eplepsyres.2010.08.012</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0920-1211 |
ispartof | Epilepsy research, 2010-12, Vol.92 (2), p.145-152 |
issn | 0920-1211 1872-6844 |
language | eng |
recordid | cdi_proquest_miscellaneous_954593101 |
source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
subjects | Adolescent Adult Anticonvulsants. Antiepileptics. Antiparkinson agents Biological and medical sciences Blood pressure Blood Pressure - physiology Electrocardiography - methods Epilepsy - physiopathology Epilepsy - therapy Female Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy Heart Rate - physiology Heart rate variability Humans Male Medical sciences Middle Aged Nervous system (semeiology, syndromes) Neurology Neuropharmacology Outcome Assessment (Health Care) - methods Pharmacology. Drug treatments Refractory epilepsy Statistics, Nonparametric Tissue Doppler imaging Vagus nerve stimulation Vagus Nerve Stimulation - methods Young Adult |
title | Cardiovascular modulation during vagus nerve stimulation therapy in patients with refractory epilepsy |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T03%3A57%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cardiovascular%20modulation%20during%20vagus%20nerve%20stimulation%20therapy%20in%20patients%20with%20refractory%20epilepsy&rft.jtitle=Epilepsy%20research&rft.au=Cadeddu,%20Christian&rft.date=2010-12-01&rft.volume=92&rft.issue=2&rft.spage=145&rft.epage=152&rft.pages=145-152&rft.issn=0920-1211&rft.eissn=1872-6844&rft.coden=EPIRE8&rft_id=info:doi/10.1016/j.eplepsyres.2010.08.012&rft_dat=%3Cproquest_cross%3E954593101%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=812134280&rft_id=info:pmid/20863665&rft_els_id=1_s2_0_S092012111000238X&rfr_iscdi=true |